Quantcast

Latest Neurocrine Biosciences Inc. Stories

2014-09-03 12:32:08

Live Audio Webcast will be on September 10, 2014 SAN DIEGO, Sept. 3, 2014 /PRNewswire/ -- Neurocrine Biosciences, Inc. (Nasdaq: NBIX) announced today that Kevin Gorman, President and Chief Executive Officer of Neurocrine Biosciences, will be presenting at the Morgan Stanley Global Healthcare Conference in New York City. The live presentation takes place on Wednesday, September 10 at 11:30am ET (8:30am PT). The presentation will be webcast and may be accessed on the Company's...

2014-08-06 16:29:09

SUCCESSFUL END-OF-PHASE II MEETING FOR NBI-98854 IN TARDIVE DYSKINESIA SAN DIEGO, Aug. 6, 2014 /PRNewswire/ -- Neurocrine Biosciences, Inc. (NASDAQ:NBIX) today announced its financial results for the quarter ended June 30, 2014. For the second quarter of 2014, the Company reported a net loss of $13.4 million, or $0.18 loss per share, compared to a net loss of $12.2 million, or $0.18 loss per share, for the same period in 2013. For the six months ended June 30, 2014, the Company...

2014-06-11 08:28:27

DATA FROM KINECT 1 AND KINECT 2 TARDIVE DYSKINESIA STUDIES SAN DIEGO, June 11, 2014 /PRNewswire/ -- Neurocrine Biosciences, Inc. (NASDAQ:NBIX) today announced that on June 11, 2014, two scientific posters associated with its study of NBI-98854 in Phase IIb clinical trials of tardive dyskinesia patients, will be presented at the 2014 Annual Congress of Parkinson's Disease and Movement Disorders in Stockholm Sweden. This annual meeting brings together over 5,000 clinicians and...

2014-05-29 12:29:23

Live Audio Webcast will be on June 5, 2014 SAN DIEGO, May 29, 2014 /PRNewswire/ -- Neurocrine Biosciences, Inc. (Nasdaq: NBIX) announced today that Kevin Gorman, President and Chief Executive Officer of Neurocrine Biosciences, will be presenting at the Jefferies 2014 Global Healthcare Conference in New York City. The live presentation takes place on Thursday, June 5 at 11:30am ET (8:30am PT). The presentation will be webcast and may be accessed on the Company's website at...

2014-05-08 12:30:07

Live Audio Webcast will be on May 15, 2014 SAN DIEGO, May 8, 2014 /PRNewswire/ -- Neurocrine Biosciences, Inc. (Nasdaq: NBIX) announced today that Kevin Gorman, President and Chief Executive Officer of Neurocrine Biosciences, will be presenting at the Bank of America Merrill Lynch 2014 Health Care Conference in Las Vegas. The live presentation takes place on Thursday, May 15 at 10:40am PT (1:40pm ET). The presentation will be webcast and may be accessed on the Company's website...

2014-05-08 08:34:15

Editor Note: For more information about this release, please scroll to bottom. LONDON, May 8, 2014 /PRNewswire/ -- The trading session on Wednesday, May 07, 2014 ended on a mixed note as the Dow Jones Industrial Average finished at 16,518.54, up 0.72% and the NASDAQ Composite closed at 4,067.67, down 0.32%. The S&P 500 finished the day 0.56% higher at 1,878.21. During the trading session eight out of ten sectors finished on a higher note. The S&P 500 Health Care Sector...

2014-05-01 12:32:53

Live Audio Webcast will be on May 8, 2014 SAN DIEGO, May 1, 2014 /PRNewswire/ -- Neurocrine Biosciences, Inc. (Nasdaq: NBIX) announced today that Kevin Gorman, President and Chief Executive Officer of Neurocrine Biosciences, will be presenting at Deutsche Bank's 39(th) Annual Health Care Conference in Boston. The live presentation takes place on Thursday, May 8 at 10:40am ET (7:40am PT). The presentation will be webcast and may be accessed on the Company's website at...

2014-04-30 16:30:22

-Endometriosis Phase III Violet Petal Study Completes Screening- SAN DIEGO, April 30, 2014 /PRNewswire/ -- Neurocrine Biosciences, Inc. (NASDAQ:NBIX) today announced its financial results for the quarter ended March 31, 2014. For the first quarter of 2014, the Company reported a net loss of $11.8 million, or $0.17 loss per share, compared to a net loss of $12.1 million, or $0.18 loss per share, for the same period in 2013. The Company's balance sheet at March 31, 2014...

2014-04-25 16:24:05

Conference Call and Webcast Scheduled For Wednesday, April 30, 2014 SAN DIEGO, April 25, 2014 /PRNewswire/ -- Neurocrine Biosciences, Inc. (Nasdaq: NBIX) announced today that the Company will report its first quarter 2014 financial results after the Nasdaq market closes on Wednesday, April 30, 2014. Neurocrine will then host a live conference call and webcast to discuss its financial results and provide a Company update Wednesday afternoon, April 30, 2014 at 5:00 p.m. Eastern Time...

2014-03-04 16:25:14

Live Audio Webcast will be on March 11, 2014 SAN DIEGO, March 4, 2014 /PRNewswire/ -- Neurocrine Biosciences, Inc. (Nasdaq: NBIX) announced today that Kevin Gorman, President and Chief Executive Officer of Neurocrine Biosciences, will be presenting at the 26(th) Annual Roth Conference in Laguna. The live presentation takes place on Tuesday, March 11 at 9:30am PT (12:30pm ET). The presentation will be webcast and may be accessed on the Company's website at...


Word of the Day
vermicular
  • Like a worm in form or movement; vermiform; tortuous or sinuous; also, writhing or wriggling.
  • Like the track or trace of a worm; appearing as if worm-eaten; vermiculate.
  • Marked with fine, close-set, wavy or tortuous lines of color; vermiculated.
  • A form of rusticated masonry which is so wrought as to appear thickly indented with worm-tracks.
This word ultimately comes from the Latin 'vermis,' worm.
Related